CompuMed (CMPD) Stock Price, News & Analysis

Company Overview

CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.

Key Stats

• Today's Range: $3.99 to $4.30
• 50-Day Range: $3.01 to $4.40
• 52-Week Range: $2.40 to $6.80
• Volume: 1,562 shs
• Average Volume: 552 shs
• Market Capitalization: $5.70 million
• P/E Ratio: 25.29
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CMPD Stock Analysis - Frequently Asked Questions

How have CMPD shares performed this year?

CompuMed's stock was trading at $3.81 at the start of the year. Since then, CMPD shares have increased by 12.9% and is now trading at $4.30.

How were CompuMed's earnings last quarter?

CompuMed Inc. (OTCMKTS:CMPD) issued its earnings results on Monday, December, 16th. The company reported $0.02 EPS for the quarter. CompuMed had a trailing twelve-month return on equity of 6.43% and a net margin of 3.13%.

When did CompuMed's stock split?

CompuMed's stock reverse split on the morning of Saturday, May 21st 2022.The 1-25 reverse split was announced on Saturday, May 21st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Saturday, May 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

How do I buy shares of CompuMed?

Shares of CMPD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CompuMed own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CompuMed investors own include Yamana Gold (AUY) and Agnico Eagle Mines (AEM).

Company Calendar

• Last Earnings: 12/16/2024
• Today: 8/09/2025
• Next Earnings (Estimated): 8/12/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:CMPD
• CIK: N/A
• Web: www.compumed.net
• Phone: (310) 258-5000
• Fax: 310-645-5880
• Employees: 8
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.17
• Trailing P/E Ratio: 25.29
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $30 thousand
• Net Margins: 3.13%
• Pretax Margin: 0.93%
• Return on Equity: 6.43%
• Return on Assets: 4.53%

Debt

• Debt-to-Equity Ratio: 0.18
• Current Ratio: 2.72
• Quick Ratio: 2.55

Sales & Book Value

• Annual Sales: $6.22 million
• Price / Sales: 0.92
• Cash Flow: $0.69 per share
• Price / Cash Flow: 6.25
• Book Value: $2.49 per share
• Price / Book: 1.73

Miscellaneous

• Outstanding Shares: 1,326,000
• Free Float: 1,034,000
• Market Cap: $5.70 million
• Optionable: Not Optionable
• Beta: N/A